Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. Net Income 2018–2025
Esperion Therapeutics Inc. annual/quarterly net income history and growth rate from 2018 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Esperion Therapeutics Inc. net income for the quarter ending March 31, 2026 was -25.2 M, a 37.72% decrease year-over-year.
- Esperion Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -109.7 M, a 53.06% increase year-over-year.
- Esperion Therapeutics Inc. annual net income for 2025 was -22.7 M, a 56.17% decrease from 2024.
- Esperion Therapeutics Inc. annual net income for 2024 was -51.7 M, a 75.27% decrease from 2023.
- Esperion Therapeutics Inc. annual net income for 2023 was -209.2 M, a 10.45% decrease from 2022.
- Esperion Therapeutics Inc. annual net income for 2022 was -233.7 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Esperion Therapeutics Inc. Net Income — FAQ
Esperion Therapeutics Inc. (ESPR) net income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Esperion Therapeutics Inc.'s net income?
Esperion Therapeutics Inc. (ESPR) reported net income of -$23M for fiscal 2025.
Where can I see ESPR's net income history?
The chart and table above show Esperion Therapeutics Inc.'s net income by year and by quarter, including the growth rate.